New Study Further Validates Environmental Benefits of Floor Refinishing Compared to Replacement
12.11.2025 12:00:00 CET | Business Wire | Press Release
A recent report and lifecycle assessment (LCA) conducted by IVL Swedish Environmental Research Institute confirms refinishing hard flooring surfaces, including wood, vinyl and linoleum, is more sustainable for the environment than replacing the flooring surfaces. This new study, which was conducted for the German market, is the next step of research inspired from a previous 2019 study conducted in Sweden. Both studies aim to evaluate the environmental impact of replacing a worn, damaged or outdated flooring surface compared to refinishing the flooring surface which may include sanding, finishing, staining, or painting.
Bona, a global, family-owned company that supplies products for installing, renovating, maintaining, and restoring premium floors, commissioned this new study to build on the findings from a 2019 Swedish study. The new research focused on Germany, a market with a population eight times larger than Sweden, and analysed a 20 square metre scenario, reflecting a smaller, domestic floor and a 100 square metre scenario looking at larger spaces. It also included linoleum, a surface not covered in the original study. Calculations followed ISO 14040/44 and Environmental Product Declaration (EPD) standards. While the new study used updated EPD standards, preventing direct comparison to the original research, the findings align closely, reinforcing similar conclusions.
"We are pleased to once again work with Bona to highlight the value of floor refinishing systems. By working long-term and conducting thorough analyses, we have gained important insights into the climate impact of floor refinishing—knowledge that not only strengthens sustainability efforts but also creates real value for Bona and their customers,” says Maria Ahlm, senior project manager at IVL Swedish Environmental Research institute.
Research Findings
- Carbon Emissions Savings: Refinishing a flooring surface reduces carbon emissions by an average of 89% for wood, 89% for vinyl flooring, and 83% for linoleum.
- Energy Savings*: Refinishing wood floors saves an average of 97% in energy use, with vinyl at 93% and linoleum at 89%.
- Global Warming Potential** (GWP): Floor replacement has a significantly higher GWP compared to refinishing—5-12 times higher for parquet, 9-10 times higher for vinyl, and 4-8 times higher for linoleum.
“Research like this drives innovation and advances our sustainability journey at Bona, helping us better understand the impacts of floor refinishing and replacement. It also highlights the significant environmental benefits of refinishing and reinforces our commitment to reducing the climate impact of our products and processes,” said Björn Johansson, Sustainability Director at Bona.
The study also highlights the importance of transport distance and electricity mix as factors influencing total climate impact. Among these, travel distance by craftsmen had the largest effect, suggesting that promoting local refinishing services could further enhance sustainability outcomes.
Johansson continued, “Our aim is to inspire both professionals and consumers to see refinishing as a key part of circular construction. With the right products and know-how, a floor can last for years without the need for replacement -- and that’s a win for both climate and economy.”
Research Background
The German market study adhered to ISO 14040/44 standards and provided a comprehensive analysis of environmental impact categories, including global warming potential, acidification, eutrophication, and the total use of renewable and non-renewable energy. It compared Bona’s refinishing systems—Traffic HD, Pure HD, Pure Colour, LinoPrime, and Classic UX—with publicly available EPDs for new flooring materials from major European manufacturers. Because Germany is a larger market than the original Swedish study, this research offered a significantly broader and more robust evaluation of environmental impacts. The analysis focused on parquet, vinyl, and linoleum flooring, using functional units of 100 square metres and 20 square metres over a 15-year period, and employed a cradle-to-grave comparative Life Cycle Assessment (LCA) methodology. View the full study here.
* While the energy savings calculations are accurate it should be stated that energy savings outcomes can fluctuate dependent upon energy mix, transport distance, etc.
** The environmental and resource impact categories assessed for the refinish and replacement of flooring were Global warming potential (GWP), Eutrophication potential in freshwater (EP), Acidification, Photochemical ozone creation potential (POCP), Total use of non-renewable primary energy (PENRT) and Total use of renewable primary energy resources (PERT).
About Bona
Bona is a global, family-owned company that supplies products for installing, renovating, maintaining and restoring premium floors. Founded in 1919, Bona pioneered the industry by offering waterborne hardwood floor finishing and floor care products. Today, Bona prioritizes the environmental impact of its product and innovates high quality systems for most premium floor surfaces including wood, tile, vinyl, resilient, rubber and laminate. The head office is in Malmö, Sweden, and the company is represented globally across 90 countries through 17 subsidiaries, 70 distributors, 4 production sites and over 700 employees. For more information visit www.bona.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251112025357/en/
Contacts
Heather Lindemann | Bona Global Corporate Communications
+1 (303) 923-6694
heather.lindemann@bona.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom